Cerevel Therapeutics Holdings Inc [CERE] Records 200-Day SMA of $31.67

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cerevel Therapeutics Holdings Inc shares valued at $2,050,550 were sold by COLES N ANTHONY on Mar 04 ’24. At $41.01 per share, COLES N ANTHONY sold 50,000 shares. The insider’s holdings dropped to 15,638 […]

A Guide To The Risks Of Investing In Cerevel Therapeutics Holdings Inc (CERE)

In a filing, Cerevel Therapeutics Holdings Inc revealed its Director COLES N ANTHONY unloaded Company’s shares for reported $2.05 million on Mar 04 ’24. In the deal valued at $41.01 per share,50,000 shares were sold. As a result of this transaction, COLES N ANTHONY now holds 15,638 shares worth roughly $0.67 million. Then, COLES N […]

Cerevel Therapeutics Holdings Inc (CERE) receives a Market perform rating from TD Cowen

Cerevel Therapeutics Holdings Inc’s recent filing unveils that its Director COLES N ANTHONY unloaded Company’s shares for reported $2.05 million on Mar 04 ’24. In the deal valued at $41.01 per share,50,000 shares were sold. As a result of this transaction, COLES N ANTHONY now holds 15,638 shares worth roughly $0.65 million. Then, COLES N […]

Short interest on CERE sees a significant increase on Feb 15, 2024

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cerevel Therapeutics Holdings Inc shares valued at $2,050,550 were sold by COLES N ANTHONY on Mar 04 ’24. At $41.01 per share, COLES N ANTHONY sold 50,000 shares. The insider’s holdings dropped to 15,638 […]

Cerevel Therapeutics Holdings Inc (CERE) rating downgrades by TD Cowen

Cerevel Therapeutics Holdings Inc’s filing revealed that its Director COLES N ANTHONY unloaded Company’s shares for reported $2.06 million on Feb 29. In the deal valued at $41.16 per share,50,000 shares were sold. As a result of this transaction, COLES N ANTHONY now holds 15,638 shares worth roughly $0.64 million. Then, COLES N ANTHONY sold […]

Analysts review Cerevel Therapeutics Holdings Inc’s rating

Cerevel Therapeutics Holdings Inc’s recent filing unveils that its Director COLES N ANTHONY unloaded Company’s shares for reported $0.1 million on Feb 07. In the deal valued at $41.54 per share,2,506 shares were sold. As a result of this transaction, COLES N ANTHONY now holds 15,638 shares worth roughly $0.64 million. Then, Renger John sold […]